![[(3S,4R)-4-(2,5-Difluorophenyl)pyrrolidin-3-yl]-methanol hydrochloride - chemical structure image](https://media.scbt.com/product/3s-4r-4-2-5-difluorophenyl-pyrrolidin-3-yl-methanol-hydrochloride-structure_23_82_b_238289.jpg)
![[(3S,4R)-4-(2,5-Difluorophenyl)pyrrolidin-3-yl]-methanol hydrochloride - chemical structure image](https://media.scbt.com/product/3s-4r-4-2-5-difluorophenyl-pyrrolidin-3-yl-methanol-hydrochloride-structure_23_82_t_238289.jpg "Molecular structure of [(3S,4R)-4-(2,5-Difluorophenyl)pyrrolidin-3-yl]-methanol hydrochloride")
[(3S,4R)-4-(2,5-Difluorophenyl)pyrrolidin-3-yl]-methanol hydrochloride
QUICK LINKS
Docosa-4Z,7Z,10Z,13Z,16Z,19Z-hexaenoic Acid (22:6, n-3) (DHA), an abundant essential n-3 polyunsaturated fatty acid in the CNS, may act to play a major anti-inflammatory role. This compound has been reported to prevent LPS-induced dendritic cell maturation, characterized by a lack of proinflammatory cytokine production. Mechanistic studies suggest that Docosa-4Z,7Z,10Z,13Z,16Z,19Z-hexaenoic Acid (22:6, n-3) causes a decrease in GATA-3, T-bet, and RORgammat, as well as an increase in p27 which is a cell cycle arresting agent. Additional research suggests that Docosa-4Z,7Z,10Z,13Z,16Z,19Z-hexaenoic Acid (22:6, n-3) also contains the ability to increase nitrite and decrease superoxide production in retinal microvascular endothelial cells. Docosa-4Z,7Z,10Z,13Z,16Z,19Z-hexaenoic Acid (22:6, n-3) is an activator of RXR alpha, RAR beta and RAR gamma.
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
[(3S,4R)-4-(2,5-Difluorophenyl)pyrrolidin-3-yl]-methanol hydrochloride, 500 mg | sc-322854 | 500 mg | $450.00 |